Cargando…

Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism

Objective: To examine the association between brain natriuretic peptide (BNP) gene single nucleotide polymorphisms (SNPs) and chronic obstructive pulmonary disease (COPD) and COPD with pulmonary hypertension (PH) and to analyze its mechanism. Methods: The genotypes of BNP at the rs198389, rs6668352,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Guangjun, Chen, Zhu, Zhang, Jiancheng, Song, Jia, Shi, Jun, Zhou, Bingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167498/ https://www.ncbi.nlm.nih.gov/pubmed/30217946 http://dx.doi.org/10.1042/BSR20180905

Ejemplares similares

Plasma brain natriuretic peptide, platelet parameters, and cardiopulmonary function in chronic obstructive pulmonary disease
por: Guo, Hai-Jian, et al.
Publicado: (2021)

Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
por: Baliga, Reshma S, et al.
Publicado: (2009)

Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
por: Casserly, Brian, et al.
Publicado: (2009)

The Utility of Brain Natriuretic Peptide in Patients Undergoing an Initial Evaluation for Pulmonary Hypertension
por: Rao, Sanjana, et al.
Publicado: (2022)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review
por: Hawkins, Nathaniel M., et al.
Publicado: (2017)

Plasma N-terminal Pro-brain Natriuretic Peptide: A Prognostic Marker in Patients with Chronic Obstructive Pulmonary Disease
por: Chi, Su Young, et al.
Publicado: (2012)

N-terminal pro-brain natriuretic peptide as a prognostic marker in patients with exacerbation of chronic obstructive pulmonary disease
por: Stamatis, P, et al.
Publicado: (2013)

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

Prognostic value of brain natriuretic peptide in acute pulmonary embolism
por: Coutance, Guillaume, et al.
Publicado: (2008)

Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease
por: Nishimura, Koichi, et al.
Publicado: (2014)

Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2022)

Value of the neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease complicated with pulmonary hypertension
por: Jiang, Tingting, et al.
Publicado: (2023)

The Combination Clinical Value of Plasma Brain Natriuretic Peptide and Serum HbAlc in the Diagnosis of Chronic Pulmonary Heart Disease
por: Jia, Enxia
Publicado: (2022)

Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
por: Aurangabadkar, Gaurang M, et al.
Publicado: (2022)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease
por: Balk-Møller, Emilie, et al.
Publicado: (2019)

Comparison of Brain Natriuretic Peptide Levels to Simultaneously Obtained Right Heart Hemodynamics in Stable Outpatients with Pulmonary Arterial Hypertension
por: Helgeson, Scott A., et al.
Publicado: (2018)

The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension
por: Khatab, Yacoub, et al.
Publicado: (2022)

Effect of azithromycin in combination with simvastatin in the treatment of chronic obstructive pulmonary disease complicated by pulmonary arterial hypertension
por: Wang, Peidong, et al.
Publicado: (2017)

Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis
por: Pavasini, Rita, et al.
Publicado: (2016)

Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
por: Baliga, R S, et al.
Publicado: (2014)

Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension
por: Nawa, Nobutoshi, et al.
Publicado: (2016)

Elevated pulmonary artery pressure and brain natriuretic peptide in high altitude pulmonary edema susceptible non-mountaineers
por: Gupta, Rajinder K., et al.
Publicado: (2016)

Assessing prognosis of pulmonary embolism using tissue-Doppler echocardiography and brain natriuretic peptide
por: Rodrigues, Ana Clara Tude, et al.
Publicado: (2013)

Differential effects of atrial and brain natriuretic peptides on human pulmonary artery: An in vitro study
por: Hussain, Azar, et al.
Publicado: (2019)

Gene polymorphisms and chronic obstructive pulmonary disease
por: Wu, Xiaodan, et al.
Publicado: (2014)

Genetic polymorphism and chronic obstructive pulmonary disease
por: Yuan, Cunhua, et al.
Publicado: (2017)

It’s Complicated: Lung Dendritic Cells in Chronic Obstructive Pulmonary Disease
por: Freeman, Christine M., et al.
Publicado: (2020)

Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life
por: Gupta, Kamlesh Kumar, et al.
Publicado: (2018)

Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment
por: Lee, Jae Chul, et al.
Publicado: (2016)

C-Type Natriuretic Peptide Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction in Rats with Pulmonary Arterial Hypertension
por: Gao, Xiaowei, et al.
Publicado: (2018)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
por: Li, Mengxi
Publicado: (2023)

N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
por: Harbaum, Lars, et al.
Publicado: (2014)

Pro-brain natriuretic peptide as a marker of successful thrombolysis in patients with submassive pulmonary thromboembolism
por: Castro, R, et al.
Publicado: (2008)

Assessment of brain natriuretic peptide and copeptin as correlates of blood pressure in chronic hypertensive pregnant women
por: Okwor, Chika J., et al.
Publicado: (2022)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8caskrdfbgifhbjha33s0sj01n